Vimarsana
Biggest News Aggregation in the World

Abstract Code News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Abstract Code. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Abstract Code Today - Breaking & Trending Today

Innovent and IASO Bio Present Updated Long-Term Follow-Up Data for BCMA CAR-T FUCASO® (Equecabtagene Autoleucel) at IMS 2023 - Vimarsana News

Innovent and IASO Bio Present Updated Long-Term Follow-Up Data for BCMA CAR-T FUCASO® (Equecabtagene Autoleucel) at IMS 2023

/PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes...

IASO Bio Presents Updated Long-Term Follow-Up Data for BCMA CAR-T FUCASO® (Equecabtagene Autoleucel) at IMS 2023 - Vimarsana News

IASO Bio Presents Updated Long-Term Follow-Up Data for BCMA CAR-T FUCASO® (Equecabtagene Autoleucel) at IMS 2023

/PRNewswire/ -- IASO Bio, a biopharmaceutical company engaged in discovering, developing, manufacturing and marketing innovative cell therapies and antibody...

Innovent Announces Phase 1 Clinical Data of IBI322 (CD47/PD-L1 Bispecific Antibody) in the Treatment of Anti-PD-(L)1-resistant Classic Hodgkin Lymphoma Patients at the EHA 2023 Annual Meeting - Vimarsana News

Innovent Announces Phase 1 Clinical Data of IBI322 (CD47/PD-L1 Bispecific Antibody) in the Treatment of Anti-PD-(L)1-resistant Classic Hodgkin Lymphoma Patients at the EHA 2023 Annual Meeting

/PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes...

Cereno Scientific : to present preclinical data for candidate drug CS585 at EHA2023 Hybrid Congress – the premier medical congress for hematology - Vimarsana News

Cereno Scientific : to present preclinical data for candidate drug CS585 at EHA2023 Hybrid Congress – the premier medical congress for hematology

Cereno Scientific ,a company developing innovative treatments for common and rare cardiovascular disease, today announced that an abstract on preclinical drug candidate CS585 has been... | May 15, 2023

Affimed Announces Abstracts at the Annual Meeting of the European Hematology Association - Vimarsana News

Affimed Announces Abstracts at the Annual Meeting of the European Hematology Association

A post-hoc subgroup analysis from the AFM13 REDIRECT study in patients with relapsed/refractory peripheral T cell lymphoma is accepted as a poster presentationA trial in progress abstract of the... | May 11, 2023